Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Edema
Description
Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. MeSH
Hierarchy View
Subtype Terms (2)
Edema, Cardiac
1 approved drug
Hydrops Fetalis
1 experimental drug
Phase 3 Indicated Drugs (3)
Phase 2 Indicated Drugs (15)
Phase 1 Indicated Drugs (3)
Other Experimental Indicated Drugs (21)
Organization Involved with Phase 4 Indications (107)
Asociación para Evitar la Ceguera en México
Association for Innovation and Biomedical Research on Light and Image (AIBILI)
Carolina Eyecare Physicians, LLC
Center For Excellence In Eye Care
Charlotte Eye Ear Nose and Throat Assciates, PA
Ciusss de L'Est de l'Île de Montréal
Federal University of Sao Paulo
Fundación Canaria Rafael Clavijo para la Investigación Biomédica
National University of Singapore
Northern California Retina Vitreous Associates
North Toronto Eye Care Laser and Eye Specialists
Ophthalmic Consultants of Long Island
Oregon Health and Science University
Parsons Medical Communications
Postgraduate Institute of Medical Education and Research
Retina-Vitreous Associates Medical Group
Organization Involved with Phase 3 Indications (74)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Beijing Bethune public welfare fund
Canadian Institutes of Health Research (CIHR)
Celtic Pharma Development Services
Chengdu Kanghong Biotech Co.,Ltd.
Chinese Academy of Medical Sciences
European Society of Cataract and Refractive Surgeons
Instituto Universitario de Oftalmobiología Aplicada
Isfahan Ophthalmology Research Center
Orthopaedische Klinik Koenig-Ludwig-Haus
Second Military Medical University
Shahid Beheshti University of Medical Sciences
The Hospital for Sick Children
Organization Involved with Phase 2 Indications (97)
Al-Farabi Kazakh National University
Black Hills Regional Eye Institute
Chinese University of Hong Kong
Cumberland Valley Retina Consultants, PC
Especialistas en Retina Medica y Quirurgica Grupo de Investigacion
Greater Houston Retina Research
Instituto Mexicano de Oftalmologia
J. Arch McNamara Research Fund
Juvenile Diabetes Research Foundation
KalVista Pharmaceuticals, Ltd.
Long Island Vitreoretinal Consultants
Mid-Atlantic Retina Consultations, Inc.
National Autonomous University of Mexico
Oncology Service, Wills Eye Institute
People's Liberation Army of China
Retina Associates of Florida, P.A.
Retinal Consultants of Arizona
Retina Vitreous Associates of Florida
Rocky Mountain Retina Consultants
Sanwa Kagaku Kenkyusho Co., Ltd.
South Coast Retina Center; Carson, McBeath, Boswell, Inc.
Organization Involved with Phase 1 Indications (26)
LTS Lohmann Therapie-Systeme AG
MingSight-Relin Pharmaceuticals Co., Ltd.
Ophthalmic Consultants of Boston
Retina Vitreous Associates Beverley Hills, California
Organization Involved with Other Experimental Indications (41)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
